Cyanate as an inhibitor of red-cell sickling.
D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002219:Carbamates / Q000097:blood / Q000378:metabolism; D002247:Carbon Isotopes; D003485:Cyanates / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D004912:Erythrocytes / Q000378:metabolism; D004913:Erythrocytes, Abnormal / Q000187:drug effects* / Q000378:metabolism; D004971:Estrus / Q000187:drug effects; D005260:Female; D006207:Half-Life; D006455:Hemoglobins, Abnormal / Q000378:metabolism; D006801:Humans; D051379:Mice; D010100:Oxygen / Q000097:blood; D011247:Pregnancy; D051381:Rats; D014508:Urea / Q000494:pharmacology / Q000627:therapeutic use
D002219:Carbamates; D002247:Carbon Isotopes; D003485:Cyanates; D006455:Hemoglobins, Abnormal; D014508:Urea; D010100:Oxygen